Biotech: Pressemitteilungen - Kategorie - Seite 3

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review Period to April 3, 2018

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 11/13/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced that it was notified today by its partner, TaiMed Biologics, Inc. ("TaiMed") ...

Trillium Therapeutics' TTI-621 Program Featured at the Society for Immunotherapy of Cancer 32nd Annual Meeting

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/13/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of ca ...

Trillium Therapeutics Reports Third Quarter 2017 Financial and Operating Results

TORONTO, ONTARIO: - Patient enrollment for both Phase 1 trials of TTI-621 exceeding expectations - TTI-621 Phase 1 trials on track for end of year clinical updates - Cash and marketable securities of $64.3 million at S ...

Bradmer Announces Third Quarter 2017 Financial and Operational Results

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/06/17 -- Bradmer Pharmaceuticals Inc. (NEX: BMR.H) ("Bradmer" or the "Company") today announced its third quarter 2017 financial results.F ...

Tauriga Sciences, Inc. Fully Retires $45,000 USD Face Value 8.00% Convertible Debenture Issued to GS Capital Partners LLC on April 27, 2017

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 11/06/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building of businesses in the life sciences space, to ...

Trillium Therapeutics to Present at Upcoming Scientific Conferences

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/06/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL) a clinical stage immuno-oncology company developing innovative therapies for the treatment of ca ...

Angle PLC: Holding(s) in Company

GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 11/06/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)(AIM:AGL OTCQX:ANPCY)Contacts: RNS Customer Services 0044-207797-4400 ...

Angle PLC: Holding(s) in Company

GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 11/06/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)(AIM:AGL OTCQX:ANPCY)Contacts: RNS Customer Services 0044-207797-4400 ...

Angle PLC: Holding(s) in Company

GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 11/06/17 -- Angle PLC (OTCQX: ANPCY) (AIM: AGL)(AIM:AGL OTCQX:ANPCY)Contacts: RNS Customer Services 0044-207797-4400 ...

Angle PLC: Holding(s) in Company

GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 11/02/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)Contacts: RNS Customer Services 0044-207797-4400 ...

Angle PLC: Completion of Fundraising and Acquisition

GUILDFORD, ENGLAND: GUILDFORD, ENGLAND -- (Marketwired) -- 11/01/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce that further to th ...

ANGLE plc: Result of AGM Location

GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 10/31/17 -- ANGLE plc (AIM: AGL) (OTCQX: ANPCY)AIM:AGL OTCQX:ANPCYANGLE plc (AIM: AGL) (OTCQX: ANPCY), a world-leading liquid biopsy company, announces that at t ...

Sermonix Pharmaceuticals Announces Recent Closure of $4.2 Million Seed Preferred Equity Bridge to Fund Operations, Prepare for Phase II Breast Cancer Study

COLUMBUS, OH: Biotechnology company will globally develop and commercialize drug for treatment of advanced metastatic breast cancer ...

ANGLE plc: Result of General Meeting

GUILDFORD, ENGLAND: GUILDFORD, ENGLAND -- (Marketwired) -- 10/30/17 -- ANGLE plc (AIM: AGL) (OTCQX: ANPCY)AIM:AGL OTCQX:ANPCYANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce ...

Microbix Completes Second Tranche of Brokered Private Placement

TORONTO, ONTARIO: Tranche Gross Proceeds of $1,164,640, Total Proceeds of $3,500,000 ...

Ceapro Inc. Announces the Launch of its Proprietary Line of Cosmeceutical Products, JUVENTE

EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 10/26/17 -- - Successful execution of Juvente(DC) Inc. acquisition marks an important step in Ceapro's strategic market diversification business plan -- New ...

Angle PLC: Total Voting Rights

GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 10/26/17 -- Angle PLC (OTCQX: ANPCY) (AIM: AGL)AIM:AGL OTCQX:ANPCYANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that, followi ...

Novoheart Strengthens North American Presence Opening New R&D Location at the World-class Cove Facility, UC Irvine, California

IRVINE, CALIFORNIA: IRVINE, CALIFORNIA -- (Marketwired) -- 10/25/17 -- Novoheart ("Novoheart" or the "Company") (TSX VENTURE: NVH), a global stem cell biotechnology company, is pleased to announce th ...

Prevtec Microbia Receives Market Authorization for Coliprotec(R) F4/F18 in Russia and CIS countries

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 10/24/17 -- Prevtec Microbia Inc. ("Prevtec") is pleased to announce that a Market Authorization was received for Russia, including all CIS countries, ...

Prevtec Microbia Receives Market Authorization for Coliprotec(R) F4/F18 in Russia and CIS countries

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 10/24/17 -- Prevtec Microbia Inc. ("Prevtec") is pleased to announce that a Market Authorization was received for Russia, including all CIS countries, ...


Seite 4 von 255:  « ..  3 4 5  6  7  8  9  10  11  12  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z